KR950703950A - 히드록시카르바졸 화합물의 항산화성 신경보호 용도 및 이를 이용한 치료 방법(Antioxidant Neuroprotective Use of, and Method of Treatment Using, Hydroxycarbazole Compounds) - Google Patents
히드록시카르바졸 화합물의 항산화성 신경보호 용도 및 이를 이용한 치료 방법(Antioxidant Neuroprotective Use of, and Method of Treatment Using, Hydroxycarbazole Compounds)Info
- Publication number
- KR950703950A KR950703950A KR1019950702200A KR19950702200A KR950703950A KR 950703950 A KR950703950 A KR 950703950A KR 1019950702200 A KR1019950702200 A KR 1019950702200A KR 19950702200 A KR19950702200 A KR 19950702200A KR 950703950 A KR950703950 A KR 950703950A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- compound
- hydrogen
- lower alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract 11
- 239000003963 antioxidant agent Substances 0.000 title abstract 3
- 230000003078 antioxidant effect Effects 0.000 title abstract 3
- QBPAUIDFWFXLKB-UHFFFAOYSA-N 9h-carbazol-1-ol Chemical class N1C2=CC=CC=C2C2=C1C(O)=CC=C2 QBPAUIDFWFXLKB-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000324 neuroprotective effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract 24
- 241000124008 Mammalia Species 0.000 claims abstract 11
- 150000003839 salts Chemical class 0.000 claims abstract 5
- 208000014674 injury Diseases 0.000 claims abstract 3
- 230000000302 ischemic effect Effects 0.000 claims abstract 3
- 210000000056 organ Anatomy 0.000 claims abstract 3
- 230000001590 oxidative effect Effects 0.000 claims abstract 3
- 230000000451 tissue damage Effects 0.000 claims abstract 3
- 231100000827 tissue damage Toxicity 0.000 claims abstract 3
- 230000008733 trauma Effects 0.000 claims abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 35
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 239000001257 hydrogen Substances 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 17
- 150000002431 hydrogen Chemical class 0.000 claims 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 239000001301 oxygen Substances 0.000 claims 8
- -1 methylenedioxy Chemical group 0.000 claims 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 4
- 125000003435 aroyl group Chemical group 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 4
- 229910052794 bromium Inorganic materials 0.000 claims 4
- 125000001589 carboacyl group Chemical group 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 4
- 239000000460 chlorine Substances 0.000 claims 4
- 229910052801 chlorine Inorganic materials 0.000 claims 4
- 235000013601 eggs Nutrition 0.000 claims 4
- 239000011737 fluorine Substances 0.000 claims 4
- 229910052731 fluorine Inorganic materials 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 4
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 230000004112 neuroprotection Effects 0.000 claims 4
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 239000011593 sulfur Substances 0.000 claims 4
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 4
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 210000005013 brain tissue Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000004792 oxidative damage Effects 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98392092A | 1992-12-01 | 1992-12-01 | |
| US07/983920 | 1992-12-01 | ||
| PCT/US1993/011598 WO1994012178A1 (en) | 1992-12-01 | 1993-12-01 | Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR950703950A true KR950703950A (ko) | 1995-11-17 |
Family
ID=25530181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950702200A Ceased KR950703950A (ko) | 1992-12-01 | 1993-12-01 | 히드록시카르바졸 화합물의 항산화성 신경보호 용도 및 이를 이용한 치료 방법(Antioxidant Neuroprotective Use of, and Method of Treatment Using, Hydroxycarbazole Compounds) |
Country Status (8)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997040680A1 (en) * | 1996-04-29 | 1997-11-06 | Smithkline Beecham Corporation | Antioxidant compound |
| EP0910374A1 (de) * | 1996-07-13 | 1999-04-28 | Roche Diagnostics GmbH | Topisch einsetzbare pharmazeutische formulierungen enthaltend als wirkstoff ein carbazolyl-(4)-oxy-propanolamin-derivat |
| US6369106B1 (en) * | 1996-12-26 | 2002-04-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Treatment of ischemic brain injuries with brain targeted anti oxidant compounds |
| JPH10251147A (ja) * | 1997-03-06 | 1998-09-22 | Akira Matsumori | 炎症性疾患の予防・治療剤 |
| AR035455A1 (es) * | 2001-04-23 | 2004-05-26 | Hoffmann La Roche | Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2815926A1 (de) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
-
1993
- 1993-11-29 ZA ZA938897A patent/ZA938897B/xx unknown
- 1993-12-01 JP JP6513451A patent/JPH08503711A/ja active Pending
- 1993-12-01 AU AU57323/94A patent/AU673882B2/en not_active Ceased
- 1993-12-01 EP EP94903351A patent/EP0671914A1/en not_active Ceased
- 1993-12-01 CN CN93120406A patent/CN1042795C/zh not_active Expired - Fee Related
- 1993-12-01 WO PCT/US1993/011598 patent/WO1994012178A1/en not_active Application Discontinuation
- 1993-12-01 CA CA002150695A patent/CA2150695A1/en not_active Abandoned
- 1993-12-01 KR KR1019950702200A patent/KR950703950A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN1098908A (zh) | 1995-02-22 |
| JPH08503711A (ja) | 1996-04-23 |
| AU673882B2 (en) | 1996-11-28 |
| CA2150695A1 (en) | 1994-06-09 |
| ZA938897B (en) | 1994-08-01 |
| WO1994012178A1 (en) | 1994-06-09 |
| AU5732394A (en) | 1994-06-22 |
| EP0671914A4 (enrdf_load_stackoverflow) | 1995-10-25 |
| EP0671914A1 (en) | 1995-09-20 |
| CN1042795C (zh) | 1999-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU695162B2 (en) | Method and means for prevention of cataract | |
| KR960701033A (ko) | 효능있는 칼슘 길항 및 산화방지 활성을 모두 갖는 화합물, 및 세포보호제로서 그것의 사용방법(compounds having both potent calcium antagonist and antioxidant activity and use there of as cytoprotective agents) | |
| KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
| KR920700200A (ko) | 19-노르-비타민 d 화합물 | |
| KR950703949A (ko) | 히드록시카르바졸 화합물의 항산화성 심장보호 용도 및 이를 이용한 치료 방법(Antioxidant Cardioprotective Use of, and Methoed of Treatment Using, Hydroxycarbazole Compounds) | |
| KR910016931A (ko) | 과콜레스테린혈증 치료제 | |
| KR890003369A (ko) | 약제학적 제제 | |
| KR920012040A (ko) | 신규의 디히드로-이소퀴놀린 유도체 | |
| KR930002335A (ko) | 케톤 유도체 | |
| KR950700265A (ko) | 고지혈증 치료에 유용한 벤조티아제핀 화합물(hypolipidaemic ben zothiazepine compounds) | |
| KR950031068A (ko) | 골다공증의 복합 치료 | |
| KR900015729A (ko) | 흥분성 아미노산 길항제 | |
| KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
| KR910016915A (ko) | 과콜레스테롤혈증 치료제 | |
| JP2004502732A5 (enrdf_load_stackoverflow) | ||
| KR880009953A (ko) | 3-아미노-디하이드로-[1]-벤조피란 및 벤조티오피란 | |
| KR950704284A (ko) | 칼슘 채널 길항제로서의 피페리딘 유도체(Piperidine Derivatives as Calcium Channel Antagonists) | |
| KR950703950A (ko) | 히드록시카르바졸 화합물의 항산화성 신경보호 용도 및 이를 이용한 치료 방법(Antioxidant Neuroprotective Use of, and Method of Treatment Using, Hydroxycarbazole Compounds) | |
| FR2506306A1 (fr) | Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique | |
| KR900016135A (ko) | 피부 및 점막-상피의 질환 치료용 4-퀴놀린 카복실산 유도체 | |
| KR950016753A (ko) | 벤조[쥐(g)]퀴놀린의 신규의 사용 방법 | |
| ES8507468A1 (es) | Procedimiento de obtencion de agentes de beta-bloqueantes conteniendo grupos ester con propiedades oftalmologicas | |
| KR900007407A (ko) | 방광질환 치료에 사용하기 위한 화합물 및 방광 질환의 치료 방법 | |
| HUP0203790A2 (hu) | (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére | |
| KR950016720A (ko) | 아밀로이드 단백질의 효과를 저해하는 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19950531 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19981130 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20000630 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20010430 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20000630 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20010602 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20010430 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20021125 Appeal identifier: 2001101001522 Request date: 20010602 |
|
| J801 | Dismissal of trial |
Free format text: REJECTION OF TRIAL FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010602 Effective date: 20021125 |
|
| PJ0801 | Rejection of trial |
Decision date: 20021125 Appeal kind category: Appeal against decision to decline refusal Appeal identifier: 2001101001522 Request date: 20010602 |